AlphaYou
Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- 52-wk high
- $122.20
- 52-wk low
- $74.50
- Prev close
- $99.39
- Mkt cap
- $7.94B
- Beta
- 1.97
- P/S
- 33.1x
Smart money
Earnings
Earnings came in 9.9% above what analysts expected.
Financials
What it sold, what it cost, what was left.
Sep 2025Dec 2025Mar 2026Jun 2026
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $51.3M | $57.3M | $60.1M | $71.3M |
| Cost of what it sold | $5.5M | $4.8M | $7.2M | $8.9M |
| Gross profit | $45.8M | $52.5M | $53.0M | $62.3M |
| What it spent | ||||
| Research and development | $46.0M | $42.0M | $41.7M | $43.4M |
| Sales and admin | $52.4M | $57.5M | $63.6M | $67.4M |
| Total operating expenses | $98.5M | $99.5M | $105.3M | $110.9M |
| What was left | ||||
| Operating profit | -$52.7M | -$47.1M | -$52.4M | -$48.6M |
| Interest on debt | $4.7M | $4.6M | $4.6M | $4.5M |
| Profit before tax | -$52.8M | -$47.5M | -$55.1M | -$48.9M |
| Tax | $111.0K | -$31.0K | $545.0K | $444.0K |
| Net profit | -$52.9M | -$47.5M | -$55.6M | -$49.3M |
| EBITDA | -$47.7M | -$42.6M | -$50.3M | -$44.1M |
Technicals
Price structure
No data yet
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
36 articles · 7 days
Coverage leans bullish
Tone of tracked coverage
Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Alastair Garfield Sells 7,763 Shares
NeutralAug 17Insider Selling: Rhythm Pharmaceuticals (NASDAQ:RYTM) Insider Sells 5,079 Shares of Stock
NeutralAug 17Rhythm Pharmaceuticals CTO Joseph Shulman sells $608,210 of stock
NeutralAug 17